Navigation Links
Wholly Guacamole Quick & Nutritious Entertaining Tips Offer 'Skinny' Dippin', Zesty Grillin' and Summertime Freedom for All
Date:7/1/2008

FORT WORTH, Texas, July 1 /PRNewswire/ -- The season's here ... bathing suits and BBQ's. According to the National BBQ Association, 31 percent of American grill owners barbecue more now than a year ago because they are trying to eat healthier. Unfortunately with quick meals a priority, making smart food choices is often a challenge. For healthier summer eating that will leave your guests wanting more, add some guacamole to the table suggests makers of top-ranked Wholly Guacamole (http://www.whollyguac.com). All-natural guacamole is the perfect food in the summer both as a super quick and nutritious dip with chips and veggies and a WOW topper for anything grilled.

#1- It's Always Cold and Ready. Pre-made, all-natural guacamole from your grocery's refrigerated produce or specialty deli section is made like you would, if you had the supplies and time-with 95 percent yummy, ripe avocados and no preservatives. Serve it straight from the pouch, or fool your friends by enhancing the classic flavor with your own chopped spices. Keep it in your fridge for 42 days-and more in the freezer for last-minute gatherings.

#2 - Go Skinny Dippin'. Made from fruit and good for you, one tablespoon of all-natural guacamole has 1/2 the calories of spinach dip and 75% less fat than most ranch dips. Try guac as a zesty low-calorie spread on your favorite sandwich or a cool, healthy snack. Three tablespoons with a hand full of baby carrots has just 94 calories -- less than a cup of low-fat milk! Awarded "Best Snack 2008" by Shape Magazine-Wholly Guacamole 100 Calorie Snack Packs help to manage portion sizes.

#3 - Choose Preservative Free. Many convenience foods add preservatives to extend shelf-life. Look for fresh, refrigerated products using High pressure processing (HPP). HPP foods, like Wholly Guacamole, retain their natural nutrients, taste, texture and color without any preservatives. Foods "cold pasteuri
'/>"/>

SOURCE Wholly Guacamole
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
2. Northfield Automation Announces Wholly Owned Subsidiary to Diversify Into Medical Device Market
3. Guacamole: Fights Hunger, Cholesterol and Cancer
4. New Guacamole 100-Calorie Packs - The Solution for Clashing February Holidays
5. Meditation a Quick Fix for Stress
6. Twinkle after effect can help retinal patients detect vision loss quickly and cheaply
7. Twinkle After-Effect Can Help Retinal Patients Detect Vision Loss Quickly and Cheaply and Prevent Further Loss
8. Thyroid treatment no quick fix for weight loss in children
9. Greenway Experiences Quick Success in the Community EHR Marketplace by Securing Contracts with 10 Community-Based Health Organizations
10. Mercury in Childhood Vaccines Excreted Quickly
11. Penn Treaty Introduces LTCi QuickPass(SM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Secretary Shinseki Announces $215 Million in Projects for Rural Veterans 2Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 2Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 3Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 4Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 5Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 6Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 7Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 8Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 9Health News:Blue Cross and Blue Shield of Georgia and Piedmont Healthcare Announce Contract Renewal 2Health News:Thousands of Canada's best minds converge at Congress 2009 2Health News:Beazley's New Management Liability Coverage is Tailored to Unique Needs of Healthcare Organizations 2Health News:Beazley's New Management Liability Coverage is Tailored to Unique Needs of Healthcare Organizations 3Health News:Study: Lower Legal Drinking Age Increases Poor Birth Outcomes 2Health News:Study: Lower Legal Drinking Age Increases Poor Birth Outcomes 3
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10Childrens Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 62578 1Childrens Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 62578 2Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 62575 1Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 62575 2VIDEO from Medialink and the American Nurses Association 28ANA 29 3A American Nurses Association Urges All Americans to Take Part in Health Care Refo 62572 1VIDEO from Medialink and the American Nurses Association 28ANA 29 3A American Nurses Association Urges All Americans to Take Part in Health Care Refo 62572 2